Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
---|---|---|---|---|---|
![]() | UMICORE | 2 | 2 | -0,23 % | |
![]() | AB INBEV | 1 | 4 | -0,07 % | |
![]() | UCB | 1 | 3 | -0,03 % | |
ARGENX | - | 8 | -0,26 % | ||
![]() | WAREHOUSES DE PAUW | - | 2 | -0,32 % | |
![]() | KBC GROEP NV | - | 1 | -0,50 % | |
![]() | ELIA GROUP | - | 1 | -0,94 % | |
![]() | SYENSQO | - | 1 | +0,10 % | |
![]() | D IETEREN GROUP | - | - | -0,57 % | |
![]() | AGEAS | - | - | -0,05 % |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Umicore Delays $2 Billion Ontario Plant as EV Demand Slows | 6 | BNN Bloomberg | ||
Fr | Umicore Non-GAAP EPS of €0.49, revenue of €1.8B; reaffirms FY24 outlook | 86 | Seeking Alpha | ||
Fr | Aktie von Anheuser-Busch NV: Kurs heute nahezu konstant (55,98 €) | 144 | ARIVA.de | Der Kurs der dem Anteilsschein von Anheuser-Busch NV kommt kaum von der Stelle. Die Aktie notiert derzeit bei 55,98 Euro. Die Wertschätzung der Börsenteilnehmer für die Aktie von Anheuser-Busch NV hat... ► Artikel lesen | |
Fr | Greencore, UCB, Unilever | 10 | Reuters | ||
Fr | Earnings call: Argenx reported an operating income of $489 million | 2 | Investing.com | ||
Do | Argenx's Vyvgart holds its own against AstraZeneca rivals in myasthenia gravis clash | 4 | FiercePharma | ||
Do | UCB SA reports 1H results | 4 | Seeking Alpha | ||
Do | Belgian logistics parks developer WDP increases portfolio in Romania to 2.2 mln sqm GLA following acquisition | 1 | Romania Insider | ||
Do | ARGENX SE - 6-K, Report of foreign issuer | - | SEC Filings | ||
Do | 'Strong' Vyvgart sales boost Argenx shares | 6 | Reuters | ||
Do | UCB rises on H1 results 'clear beat' | 9 | Reuters | ||
Do | Argenx SE beats top-line and bottom-line estimates; updates FY24 outlook | 4 | Seeking Alpha | ||
Do | argenx SE: argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update | 111 | GlobeNewswire (Europe) | $478 million in second quarter global net product sales First CIDP patients treated with VYVGART® Hytrulo following June 21st FDA approval On track to begin four additional registrational studies... ► Artikel lesen | |
Mi | Argenx SE 1H Earnings Preview | 3 | Seeking Alpha | ||
Mi | Oppenheimer upgrades Argenx to outperform, cites Vyvgart Hytrulo | 2 | Seeking Alpha | ||
Mi | Neues Gastrokonzept von AB InBev: Im "Tscharlie's" kommt das Löwenbräu aus dem Tank | 3 | about-drinks.com | ||
Mi | Anheuser-Busch NV-Aktie: Kurs nur geringfügig im Minus (55,78 €) | 188 | ARIVA.de | CODE Die Aktie notiert gegenwärtig bei 55,78 Euro. Der Kurs der Aktie von Anheuser-Busch NV zeigt sich zur Stunde kaum verändert im Vergleich zu der letzten Notierung des vorigen Handelstages. Aktuell... ► Artikel lesen | |
Mi | Elia Group SA/NV GAAP EPS of EUR 2.47, revenue of EUR 1.91B | 2 | Seeking Alpha | ||
Di | Nielsen winners include Coca-Cola, Celsius Holdings, and Anheuser-Busch InBev | 22 | Seeking Alpha | ||
Di | KBC Groep: Update regarding the KBC Group share buyback programme | 183 | GlobeNewswire (Europe) | Within the framework of the share buyback programme announced on 10 August 2023 after trading hours, KBC Group NV wishes to advise that the following transactions took place on Euronext Brussels' regulated... ► Artikel lesen |